Literature DB >> 28386793

Spinal Cord Damage in Spinocerebellar Ataxia Type 1.

Carlos Roberto Martins1, Alberto Rolim Muro Martinez1, Thiago Junqueira Ribeiro de Rezende1, Lucas Melo Teixeira Branco1, José Luiz Pedroso2, Orlando G P Barsottini2, Iscia Lopes-Cendes3, Marcondes C França4,5.   

Abstract

Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant disorder caused by a CAG repeat expansion, characterized by progressive cerebellar ataxia and pyramidal signs. Non-motor and extracerebellar symptoms may occur. MRI-based studies in SCA1 focused in the cerebellum and connections, but there are no data about cord damage in the disease and its clinical relevance. To evaluate in vivo spinal cord damage in SCA1, a group of 31 patients with SCA1 and 31 age- and gender-matched healthy controls underwent MRI on a 3T scanner. We used T1-weighted 3D images to estimate the cervical spinal cord area (CA) and eccentricity (CE) at three C2/C3 levels based on a semi-automatic image segmentation protocol. The scale for assessment and rating of ataxia (SARA) was used to quantify disease severity. The groups were significantly different regarding CA (47.26 ± 7.4 vs. 68.8 ± 5.7 mm2, p < 0.001) and CE values (0.803 ± 0.044 vs. 0.774 ± 0.043, p < 0.05). Furthermore, in the patient group, CA presented significant correlation with SARA scores (R = -0.633, p < 0.001) and CAGn expansion (R = -0.658, p < 0.001). CE was not associated with SARA scores (p = 0.431). In the multiple variable regression, CA was strongly associated with disease duration (coefficient -0.360, p < 0.05) and CAGn expansion (coefficient -1.124, p < 0.001). SCA1 is characterized by cervical cord atrophy and anteroposterior flattening. Morphometric analyses of the spinal cord MRI might be a useful biomarker in the disease.

Entities:  

Keywords:  Ataxia; Biomarker; MRI; Polyglutamine disorders; Spinal cord; Spinocerebellar ataxia type 1

Mesh:

Year:  2017        PMID: 28386793     DOI: 10.1007/s12311-017-0854-9

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  22 in total

1.  Autosomal dominant cerebellar ataxia type I clinical features and MRI in families with SCA1, SCA2 and SCA3.

Authors:  K Bürk; M Abele; M Fetter; J Dichgans; M Skalej; F Laccone; O Didierjean; A Brice; T Klockgether
Journal:  Brain       Date:  1996-10       Impact factor: 13.501

2.  Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6.

Authors:  Ullrich Wüllner; Michael Reimold; Michael Abele; Katrin Bürk; Martina Minnerop; Bernd-Michael Dohmen; Hans-Juergen Machulla; Roland Bares; Thomas Klockgether
Journal:  Arch Neurol       Date:  2005-08

3.  The natural history of degenerative ataxia: a retrospective study in 466 patients.

Authors:  T Klockgether; R Lüdtke; B Kramer; M Abele; K Bürk; L Schöls; O Riess; F Laccone; S Boesch; I Lopes-Cendes; A Brice; R Inzelberg; N Zilber; J Dichgans
Journal:  Brain       Date:  1998-04       Impact factor: 13.501

Review 4.  The neuropathology of CAG repeat diseases: review and update of genetic and molecular features.

Authors:  Y Robitaille; I Lopes-Cendes; M Becher; G Rouleau; A W Clark
Journal:  Brain Pathol       Date:  1997-07       Impact factor: 6.508

Review 5.  Autosomal dominant spinocerebellar degenerations. Clinical, pathological, and genetic correlations.

Authors:  K Iwabuchi; K Tsuchiya; T Uchihara; S Yagishita
Journal:  Rev Neurol (Paris)       Date:  1999-04       Impact factor: 2.607

6.  Spinal cord damage in Machado-Joseph disease.

Authors:  Camila N Fahl; Lucas Melo T Branco; Felipe P G Bergo; Anelyssa D'Abreu; Iscia Lopes-Cendes; Marcondes C França
Journal:  Cerebellum       Date:  2015-04       Impact factor: 3.847

7.  SCA1 patients may present as hereditary spastic paraplegia and must be included in spastic-ataxias group.

Authors:  José Luiz Pedroso; Paulo Victor Sgobbi de Souza; Wladimir Bocca Vieira de Rezende Pinto; Pedro Braga-Neto; Marcus Vinicius Cristino Albuquerque; Maria Luiza Saraiva-Pereira; Laura Bannach Jardim; Orlando Graziani Povoas Barsottini
Journal:  Parkinsonism Relat Disord       Date:  2015-07-22       Impact factor: 4.891

8.  Gametic and somatic tissue-specific heterogeneity of the expanded SCA1 CAG repeat in spinocerebellar ataxia type 1.

Authors:  S S Chong; A E McCall; J Cota; S H Subramony; H T Orr; M R Hughes; H Y Zoghbi
Journal:  Nat Genet       Date:  1995-07       Impact factor: 38.330

9.  Identification and characterization of the gene causing type 1 spinocerebellar ataxia.

Authors:  S Banfi; A Servadio; M Y Chung; T J Kwiatkowski; A E McCall; L A Duvick; Y Shen; E J Roth; H T Orr; H Y Zoghbi
Journal:  Nat Genet       Date:  1994-08       Impact factor: 38.330

10.  Multimodal MRI-based study in patients with SPG4 mutations.

Authors:  Thiago J R Rezende; Milena de Albuquerque; Gustavo M Lamas; Alberto R M Martinez; Brunno M Campos; Raphael F Casseb; Cynthia B Silva; Lucas M T Branco; Anelyssa D'Abreu; Iscia Lopes-Cendes; Fernando Cendes; Marcondes C França
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

View more
  11 in total

Review 1.  Dilemma of multiple system atrophy and spinocerebellar ataxias.

Authors:  Ming Li; Qianqian Ma; Xing Zhao; Can Wang; Huijie Wu; Jinyao Li; Wei Yang
Journal:  J Neurol       Date:  2018-04-26       Impact factor: 4.849

2.  Embryonic Cerebellar Graft Morphology Differs in Two Mouse Models of Cerebellar Degeneration.

Authors:  Zdenka Purkartova; Filip Tichanek; Yaroslav Kolinko; Jan Cendelin
Journal:  Cerebellum       Date:  2019-10       Impact factor: 3.847

3.  Structural signature in SCA1: clinical correlates, determinants and natural history.

Authors:  Carlos Roberto Martins Junior; Alberto Rolim Muro Martinez; Ingrid Faber Vasconcelos; Thiago Junqueira Ribeiro de Rezende; Raphael Fernandes Casseb; Jose Luiz Pedroso; Orlando Graziani Povoas Barsottini; Íscia Lopes-Cendes; Marcondes Cavalcante França
Journal:  J Neurol       Date:  2018-10-15       Impact factor: 4.849

Review 4.  The extra-cerebellar effects of spinocerebellar ataxia type 1 (SCA1): looking beyond the cerebellum.

Authors:  Victor Olmos; Neha Gogia; Kimberly Luttik; Fatema Haidery; Janghoo Lim
Journal:  Cell Mol Life Sci       Date:  2022-07-08       Impact factor: 9.207

Review 5.  Polymerases and DNA Repair in Neurons: Implications in Neuronal Survival and Neurodegenerative Diseases.

Authors:  Xiaoling Li; Guanghui Cao; Xiaokang Liu; Tie-Shan Tang; Caixia Guo; Hongmei Liu
Journal:  Front Cell Neurosci       Date:  2022-06-30       Impact factor: 6.147

Review 6.  Pathogenic mechanisms underlying spinocerebellar ataxia type 1.

Authors:  Leon Tejwani; Janghoo Lim
Journal:  Cell Mol Life Sci       Date:  2020-04-18       Impact factor: 9.261

Review 7.  Conventional MRI findings in hereditary degenerative ataxias: a pictorial review.

Authors:  Sirio Cocozza; Giuseppe Pontillo; Giovanna De Michele; Martina Di Stasi; Elvira Guerriero; Teresa Perillo; Chiara Pane; Anna De Rosa; Lorenzo Ugga; Arturo Brunetti
Journal:  Neuroradiology       Date:  2021-03-17       Impact factor: 2.804

Review 8.  Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view.

Authors:  Giulia Coarelli; Alexis Brice; Alexandra Durr
Journal:  F1000Res       Date:  2018-11-12

Review 9.  Neuroradiological Findings in the Spinocerebellar Ataxias.

Authors:  Alex Tiburtino Meira; Walter Oleschko Arruda; Sergio Eiji Ono; Arnolfo de Carvalho Neto; Salmo Raskin; Carlos Henrique F Camargo; Hélio Afonso G Teive
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-09-26

10.  Cervical Spinal Cord Degeneration in Spinocerebellar Ataxia Type 7.

Authors:  C R Hernandez-Castillo; R Diaz; T J R Rezende; I Adanyeguh; I H Harding; F Mochel; J Fernandez-Ruiz
Journal:  AJNR Am J Neuroradiol       Date:  2021-07-01       Impact factor: 4.966

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.